Does new Alzheimer's drug work? Answers may miss 2030 target
By Matthew Perrone Associated Press WASHINGTON (AP) - When a controversial Alzheimer's drug won U.S. approval, surprise over the decision quickly turned to shock at how long it mig…
By Matthew Perrone Associated Press WASHINGTON (AP) - When a controversial Alzheimer's drug won U.S. approval, surprise over the decision quickly turned to shock at how long it mig…